Skip to main content

and
  1. Article

    Open Access

    The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation

    Aberrant DNA methylation patterns are a prominent feature of cancer. Methylation of DNA is mediated by the DNA methyltransferase (DNMT) protein family, which regulates de novo (DNMT3A and DNMT3B) and maintenance ...

    Balpreet Bhogal, Barbara A. Weir, Ramona Crescenzo, Ann Marien in Communications Biology (2022)

  2. No Access

    Article

    Next-generation characterization of the Cancer Cell Line Encyclopedia

    Large panels of comprehensively characterized human cancer models, including the Cancer Cell Line Encyclopedia (CCLE), have provided a rigorous framework with which to study genetic variants, candidate targets...

    Mahmoud Ghandi, Franklin W. Huang, Judit Jané-Valbuena, Gregory V. Kryukov in Nature (2019)

  3. No Access

    Article

    Small-molecule targeting of brachyury transcription factor addiction in chordoma

    Chordoma is a primary bone cancer with no approved therapy1. The identification of therapeutic targets in this disease has been challenging due to the infrequent occurrence of clinically actionable somatic mutati...

    Tanaz Sharifnia, Mathias J. Wawer, Ting Chen, Qing-Yuan Huang in Nature Medicine (2019)

  4. No Access

    Article

    Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells

    CERES is a new computational method to estimate gene-dependency levels from CRISPR–Cas9 essentiality screens while accounting for copy number effects and variable sgRNA activity. Applying CERES to new genome-s...

    Robin M Meyers, Jordan G Bryan, James M McFarland, Barbara A Weir in Nature Genetics (2017)

  5. No Access

    Article

    Characterizing genomic alterations in cancer by complementary functional associations

    Complementary genomic features associated with pathway activation, gene dependency and drug sensitivity are uncovered using REVEALER.

    Jong Wook Kim, Olga B Botvinnik, Omar Abudayyeh, Chet Birger in Nature Biotechnology (2016)

  6. No Access

    Article

    High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines

    A method called PRISM rapidly identifies drug candidates that are effective against specific cancer cell lines.

    Channing Yu, Aristotle M Mannan, Griselda Metta Yvone in Nature Biotechnology (2016)

  7. Article

    Erratum: Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

    Scientific Data 1:140035 doi: 10.1038/sdata.2014.35 (2014); Published 30 September 2014; Updated 11 November 2014 The original version of this Data Descriptor contained a typographical error in the spelling of...

    Glenn S Cowley, Barbara A Weir, Francisca Vazquez, Pablo Tamayo in Scientific Data (2014)

  8. Article

    Open Access

    Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

    Using a genome-scale, lentivirally delivered shRNA library, we performed massively parallel pooled shRNA screens in 216 cancer cell lines to identify genes that are required for cell proliferation and/or viabi...

    Glenn S Cowley, Barbara A Weir, Francisca Vazquez, Pablo Tamayo in Scientific Data (2014)

  9. No Access

    Article

    Absolute quantification of somatic DNA alterations in human cancer

    Tumors vary in their ratio of normal to cancerous cells and in their genomic copy number. Carter et al. describe an analytic method for inferring the purity and ploidy of a tumor sample, enabling longitudinal stu...

    Scott L Carter, Kristian Cibulskis, Elena Helman, Aaron McKenna in Nature Biotechnology (2012)

  10. No Access

    Article

    Towards patient-based cancer therapeutics

    Orienting cancer drug discovery to the patient requires relating the genetic features of tumors to acquired gene and pathway dependencies and identifying small-molecule therapeutics that target them.

    Stuart L Schreiber, Alykhan F Shamji, Paul A Clemons, Cindy Hon in Nature Biotechnology (2010)

  11. No Access

    Article

    Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

    Samuel Singer and colleagues report an integrative genomic analysis of soft-tissue sarcomas. They survey sequence, copy number and mRNA expression in 207 individuals diagnosed with one of seven major high-grad...

    Jordi Barretina, Barry S Taylor, Shantanu Banerji, Alexis H Ramos in Nature Genetics (2010)

  12. No Access

    Article

    The landscape of somatic copy-number alteration across human cancers

    A powerful way to discover key genes with causal roles in oncogenesis is to identify genomic regions that undergo frequent alteration in human cancers. Here we present high-resolution analyses of somatic copy-...

    Rameen Beroukhim, Craig H. Mermel, Dale Porter, Guo Wei, Soumya Raychaudhuri in Nature (2010)

  13. No Access

    Article

    Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

    Mutations in genes of the RAS family are preset on about 20% of human cancers, making RAS proteins prime potential targets for cancer therapy. Direct targeting of RAS proteins has not so far been productive, but ...

    David A. Barbie, Pablo Tamayo, Jesse S. Boehm, So Young Kim, Susan E. Moody in Nature (2009)

  14. No Access

    Article

    SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

    Matthew Meyerson and colleagues report that SOX2, which encodes a transcription factor necessary for normal esophageal development, is an amplified lineage survival oncogene in lung and esophageal squamous cell c...

    Adam J Bass, Hideo Watanabe, Craig H Mermel, Soyoung Yu, Sven Perner in Nature Genetics (2009)

  15. No Access

    Article

    Somatic mutations affect key pathways in lung adenocarcinoma

    Determining the genetic basis of cancer requires comprehensive analyses of large collections of histopathologically well-classified primary tumours. Here we report the results of a collaborative study to disco...

    Li Ding, Gad Getz, David A. Wheeler, Elaine R. Mardis, Michael D. McLellan in Nature (2008)

  16. Article

    Open Access

    Major copy proportion analysis of tumor samples using SNP arrays

    Single nucleotide polymorphisms (SNPs) are the most common genetic variations in the human genome and are useful as genomic markers. Oligonucleotide SNP microarrays have been developed for high-throughput geno...

    Cheng Li, Rameen Beroukhim, Barbara A Weir, Wendy Winckler in BMC Bioinformatics (2008)

  17. Article

    Open Access

    Characterizing the cancer genome in lung adenocarcinoma

    A wide-ranging overview of genetic alterations in lung adenocarcinomas, published in this issue, takes a new approach to genome analysis. The analysis of 371 tumours revealed 31 recurrent focal events, only si...

    Barbara A. Weir, Michele S. Woo, Gad Getz, Sven Perner, Li Ding, Rameen Beroukhim in Nature (2007)

  18. No Access

    Chapter

    Targeted Brownfields Assessment of a Former Power Plant Using the Triad Approach

    A Targeted Brownfields Assessment of a former power plant was conducted using the Triad approach, through the efforts of EPA Region I and Metcalf & Eddy, the Brownfields Technology Support Center, and the town...

    Barbara A. Weir, James P. Byrne, Robert Howe in Contaminated Soils, Sediments and Water (2006)